HC Advisors LLC Sells 2,604 Shares of HealthEquity, Inc. (NASDAQ:HQY)

HC Advisors LLC lowered its position in HealthEquity, Inc. (NASDAQ:HQY) by 22.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 9,030 shares of the company’s stock after selling 2,604 shares during the period. HealthEquity accounts for about 0.7% of HC Advisors LLC’s holdings, making the stock its 22nd biggest position. HC Advisors LLC’s holdings in HealthEquity were worth $866,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also added to or reduced their stakes in HQY. Arcadia Investment Management Corp MI bought a new position in shares of HealthEquity in the fourth quarter valued at approximately $26,000. Proficio Capital Partners LLC bought a new position in shares of HealthEquity in the fourth quarter valued at approximately $39,000. UMB Bank n.a. lifted its holdings in shares of HealthEquity by 65.6% in the fourth quarter. UMB Bank n.a. now owns 414 shares of the company’s stock valued at $40,000 after purchasing an additional 164 shares in the last quarter. First Horizon Advisors Inc. lifted its holdings in shares of HealthEquity by 50.7% in the fourth quarter. First Horizon Advisors Inc. now owns 1,115 shares of the company’s stock valued at $107,000 after purchasing an additional 375 shares in the last quarter. Finally, Quarry LP lifted its holdings in shares of HealthEquity by 418.8% in the third quarter. Quarry LP now owns 1,349 shares of the company’s stock valued at $110,000 after purchasing an additional 1,089 shares in the last quarter. Institutional investors own 99.55% of the company’s stock.

Analyst Upgrades and Downgrades

HQY has been the topic of a number of recent research reports. BTIG Research raised their target price on HealthEquity from $110.00 to $130.00 and gave the company a “buy” rating in a report on Thursday, November 14th. Mizuho began coverage on HealthEquity in a research report on Wednesday, December 4th. They set an “outperform” rating and a $126.00 price target for the company. Royal Bank of Canada increased their price target on HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a research report on Tuesday, December 10th. JMP Securities increased their price target on HealthEquity from $105.00 to $107.00 and gave the company a “market outperform” rating in a research report on Tuesday, December 10th. Finally, The Goldman Sachs Group began coverage on HealthEquity in a research report on Friday, November 15th. They set a “neutral” rating and a $108.00 price target for the company. One investment analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the stock. Based on data from MarketBeat.com, HealthEquity presently has a consensus rating of “Moderate Buy” and an average price target of $113.54.

Insider Transactions at HealthEquity

In other news, Director Stuart B. Parker sold 25,000 shares of the firm’s stock in a transaction on Thursday, December 12th. The stock was sold at an average price of $96.72, for a total value of $2,418,000.00. Following the completion of the transaction, the director now directly owns 19,061 shares of the company’s stock, valued at $1,843,579.92. This trade represents a 56.74 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Robert W. Selander sold 5,750 shares of the firm’s stock in a transaction on Monday, February 10th. The stock was sold at an average price of $111.29, for a total value of $639,917.50. Following the completion of the transaction, the director now directly owns 78,219 shares of the company’s stock, valued at $8,704,992.51. The trade was a 6.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 39,000 shares of company stock valued at $3,895,788 over the last three months. Company insiders own 2.20% of the company’s stock.

HealthEquity Stock Performance

NASDAQ:HQY opened at $107.05 on Friday. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20. The business has a fifty day simple moving average of $104.84 and a two-hundred day simple moving average of $93.08. HealthEquity, Inc. has a 1 year low of $65.01 and a 1 year high of $115.59. The company has a market capitalization of $9.28 billion, a P/E ratio of 98.21, a P/E/G ratio of 1.60 and a beta of 0.55.

HealthEquity (NASDAQ:HQY) last released its earnings results on Monday, December 9th. The company reported $0.59 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.71 by ($0.12). HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. During the same period in the previous year, the company earned $0.40 earnings per share. On average, analysts expect that HealthEquity, Inc. will post 2.32 earnings per share for the current year.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.